Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Applied Therapeutics has raised $100.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2024.
Applied Therapeutics's investors include Janus Henderson Investors, Adage Capital Management, Perceptive Advisors, Frazier Life Sciences, Alexandria Venture Investments.
Applied Therapeutics is headquartered in New York, United States.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Applied Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Applied Therapeutics — Funding & Investors." VCBacked, February 28, 2024, https://www.vcbacked.co/company/applied-therapeutics. Accessed November 14, 2026.
VCBacked. (2024). Applied Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/applied-therapeutics
{{cite web |title=Applied Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/applied-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Applied Therapeutics? Request a listing update